SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-014895
Filing Date
2020-08-06
Accepted
2020-08-06 17:26:18
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 540109
2 ex1-2.htm EX-1.2 269602
3 ex5-1.htm EX-5.1 12815
4 ex31-1.htm EX-31.1 22441
5 ex31-2.htm EX-31.2 20148
6 ex32-1.htm EX-32.1 6555
7 ex32-2.htm EX-32.2 6611
  Complete submission text file 0001493152-20-014895.txt   3958799

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE crbp-20200630.xml EX-101.INS 492216
9 XBRL SCHEMA FILE crbp-20200630.xsd EX-101.SCH 58310
10 XBRL CALCULATION FILE crbp-20200630_cal.xml EX-101.CAL 51883
11 XBRL DEFINITION FILE crbp-20200630_def.xml EX-101.DEF 196010
12 XBRL LABEL FILE crbp-20200630_lab.xml EX-101.LAB 374483
13 XBRL PRESENTATION FILE crbp-20200630_pre.xml EX-101.PRE 281730
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 201082902
SIC: 2834 Pharmaceutical Preparations